Compare · BDX vs TNON
BDX vs TNON
Side-by-side comparison of Becton Dickinson and Company (BDX) and Tenon Medical Inc. (TNON): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BDX and TNON operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- BDX is the larger of the two at $48.98B, about 19438.5x TNON ($2.5M).
- Over the past year, BDX is down 4.6% and TNON is down 93.8% - BDX leads by 89.2 points.
- TNON has been more active in the news (22 items in the past 4 weeks vs 6 for BDX).
- BDX has more recent analyst coverage (25 ratings vs 0 for TNON).
- Company
- Becton Dickinson and Company
- Tenon Medical Inc.
- Price
- -
- -
- Market cap
- $48.98B
- $2.5M
- 1M return
- +0.11%
- -59.10%
- 1Y return
- -4.62%
- -93.82%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 2022
- News (4w)
- 6
- 22
- Recent ratings
- 25
- 0
Becton Dickinson and Company
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps, dedicated disposables, IV fluids, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for high-throughput single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Tenon Medical Inc.
Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It focuses on sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was incorporated in 2012 and is based in Los Gatos, California.
Latest BDX
- EVP & Chief Financial Officer Roque Vitor covered exercise/tax liability with 190 shares, decreasing direct ownership by 2% to 8,041 units (SEC Form 4) (withholding tax)
- EVP, Chief Revenue Officer Feld Michael sold $31,101 worth of shares (165 units at $188.49) as part of a pre-agreed trading plan, decreasing direct ownership by 0.83% to 19,720 units (SEC Form 4)
- BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation
- BD to Present at Wells Fargo 21st Annual Healthcare Conference
- EVP, Chief Revenue Officer Feld Michael covered exercise/tax liability with 1,049 shares, decreasing direct ownership by 5% to 19,885 units (SEC Form 4) (for withholding tax)
- BD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to Retire
- Chairman, CEO and President Polen Thomas E Jr exercised 43,278 shares at a strike of $167.25, returned $7,238,310 worth of shares to the company (39,126 units at $185.00) and sold $768,120 worth of shares (4,152 units at $185.00) as part of a pre-agreed trading plan (SEC Form 4)
- EVP and President, EMEA Goette Roland sold $440,888 worth of shares (2,438 units at $180.84), decreasing direct ownership by 14% to 14,856 units (SEC Form 4)
- BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial
- SEC Form 4 filed by Director Huffines Robert Luther
Latest TNON
- Four Biotech Stories Heating Up Right Now
- Tenon Medical Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Tenon Medical Announces Early Repayment of Its Convertible Notes
- Large owner Hrt Financial Lp bought $6,599 worth of shares (1,658 units at $3.98) and sold $5,572 worth of shares (1,506 units at $3.70), increasing direct ownership by 8% to 1,946 units (SEC Form 4)
- SEC Form EFFECT filed by Tenon Medical Inc.
- SEC Form D filed by Tenon Medical Inc.
- Large owner Hrt Financial Lp bought $8,180 worth of shares (1,790 units at $4.57) and sold $2,038 worth of shares (450 units at $4.53), increasing direct ownership by 295% to 1,794 units (SEC Form 4)
- Amendment: SEC Form S-3/A filed by Tenon Medical Inc.
- Large owner Hrt Financial Lp bought $102,458 worth of shares (18,357 units at $5.58) and sold $57,334 worth of shares (8,299 units at $6.91) (SEC Form 4)
- Tenon Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits